Introduction
Computer vision has revolutionized the medical field by offering powerful tools for the early detection of serious diseases. Thanks to artificial intelligence, diagnoses have become more accurate and faster.
This technological advance has brought about a significant transformation in the way healthcare professionals approach cancer screening and treatment. Today, we explore how these technologies have evolved and their impact on radiology.
In this article, we will examine the progress made in cancer detection, the key technologies used, and the outlook for the future.
Context and Evolution
The Pioneers (2015-2020)
In the mid-2010s, computer vision began to emerge as a viable tool for medical applications. Early research focused on analyzing medical images to identify potentially cancerous abnormalities.
Progress was rapid, with algorithms able to match, or even exceed, radiologists on certain detection tasks, such as breast cancer screening on mammograms (McKinney et al., Nature, 2020). This paved the way for innovations that transformed clinical practice.
The pioneers of this period laid the foundations of what would become a revolution in medical diagnosis.
The Post-COVID Boom (2020-2025)
The COVID-19 pandemic accelerated the adoption of digital technologies in the healthcare sector. Computer vision systems played a crucial role in managing the health crisis.
Hospitals rapidly integrated AI to optimize screening and treatment operations. This period saw an exponential increase in the use of computer vision tools.
As a result, the capabilities of these systems improved considerably, enabling earlier and more reliable cancer detection.
Clinical Applications
Breast Cancer Detection
Breast cancer is one of the first conditions to have benefited from advances in computer vision. Systems such as the mammography screening model developed by Google Health or Lunit INSIGHT MMG (Lunit) analyze mammograms to detect tumors invisible to the naked eye.
On certain well-defined detection tasks, these systems match or exceed the performance of a radiologist working alone — the comparison depending heavily on the evaluation protocol. This has improved early detection rates.
Lung Cancer
Lung cancer, known for being difficult to detect early, has also benefited from technological progress. Solutions such as Aidoc or AI-Rad Companion (Siemens Healthineers) analyze chest scans to identify small lesions that may indicate early-stage cancer.
By integrating AI into the screening process, practitioners can make better-informed decisions and improve clinical outcomes.
Other Applications
- Diabetic retinopathy
- Bone fractures
- Cardiac conditions
Key Technologies
Convolutional Neural Networks (CNN)
Convolutional neural networks are at the heart of advances in computer vision. They enable the automatic extraction of complex features from medical images.
These networks are particularly effective at pattern recognition in high-resolution images, such as CT scans and MRIs. This capability has been decisive in improving diagnostic accuracy.
CNNs continue to evolve, incorporating innovations such as regularization and transfer learning to improve their performance.
Vision Transformers (ViT)
More recently, Vision Transformers have emerged as a promising alternative to CNNs. They use attention mechanisms to analyze images as a whole, rather than focusing on specific parts.
This approach allows a better contextual understanding of images, which is crucial for accurate and rapid analysis. ViTs are redefining industry standards.
Their ability to process large amounts of data efficiently makes them a valuable tool for augmented radiology.
Players and Ecosystem
Tech Giants
Companies such as Google Health, IBM Watson Health, and Microsoft play a key role in developing and deploying computer vision technologies in the medical field.
These giants invest heavily in research and development to improve algorithms and prediction models. Their AI expertise enables them to offer innovative and effective solutions.
Their collaboration with medical institutions and researchers has led to significant advances in the detection and treatment of diseases.
Innovative Startups
Startups such as Aidoc, Zebra Medical, and Lunit bring new perspectives and solutions to the challenges of computer vision. Their agility and ability to innovate quickly place them at the forefront of this revolution.
These companies often focus on specific niches, such as detecting rare conditions or optimizing medical workflows. Their unique, specialized approach contributes to the emergence of new clinical applications.
By collaborating with hospitals and research centers, they are accelerating the adoption of AI in the medical sector.
Medical Device Manufacturers
Medical manufacturers such as Siemens Healthineers, GE Healthcare, and Philips play a crucial role by integrating computer vision solutions into their diagnostic equipment.
These companies develop devices capable of capturing high-quality medical images, which are essential for accurate analysis. Their expertise in medical engineering allows hardware and software to be combined optimally.
Their commitment to innovation continues to drive the adoption of these technologies in healthcare facilities worldwide.
Challenges and Ethical Issues
Algorithmic Bias
One of the main challenges of computer vision is ensuring that algorithms do not reproduce the biases present in training data. Particular attention must be paid to the diversity of the datasets used.
Biases can lead to erroneous diagnoses, mainly affecting underrepresented populations. Researchers and developers are working to mitigate these biases to ensure the fairness of AI systems.
However, much remains to be done to fully understand the impact of these biases and correct them effectively.
Regulation and Certification
Regulating medical devices that incorporate AI is essential to guarantee their safety and effectiveness. Health agencies, such as the FDA, have established regulatory frameworks to evaluate these technologies.
Certification processes can be long and complex, which may slow innovation. Companies must navigate these regulations to bring their products to market.
Efforts are under way to harmonize regulatory processes globally, thereby facilitating the adoption of these technologies.
Acceptance by Practitioners
Acceptance of computer vision technologies by healthcare professionals is crucial to their success. Practitioners must be convinced of the reliability and usefulness of these systems in order to integrate them into their practice.
Training and demonstrations of effectiveness are often needed to overcome initial resistance. Collaboration between developers and healthcare professionals is essential to adapt tools to clinical needs.
This transition is under way, with growing adoption of AI technologies in hospitals and clinics.
Outlook 2025-2030
The next five years should see even broader adoption of computer vision technologies in radiology. AI systems will continue to improve, offering more accurate and personalized diagnoses.
Collaborations between technology companies, startups, and medical institutions will be key to developing new applications. This convergence of expertise will accelerate innovation.
Evolving regulations and practitioners' growing acceptance of AI will contribute to establishing higher standards of care. These advances will transform the medical landscape for decades to come.
While computer vision is transforming medical imaging, artificial intelligence is advancing just as quickly in language and conversation. This is the field Koaee works in: multilingual conversational assistants for businesses, in sixteen languages, with servers located in Europe and no conversations retained. Our assistants are built on cutting-edge technologies such as Voxtral (Mistral) and GPT (OpenAI).
Conclusion
Computer vision represents a turning point in healthcare, offering unprecedented ways to improve the diagnosis and treatment of diseases. Its applications in early cancer detection and augmented radiology are already tangible.
As we move toward widespread adoption, the challenges related to bias, regulation, and practitioner acceptance will need to be addressed. The outlook is promising, and the benefits for patients are considerable.
Source: “International evaluation of an AI system for breast cancer screening”, Nature, January 2020. Original sentence in Nature: “We show an absolute reduction of 5.7% and 1.2% (USA and UK) in false positives and 9.4% and 2.7% in false negatives.”
